{
    "eid": "2-s2.0-85069864372",
    "title": "Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients",
    "cover-date": "2019-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Area under the serum concentration-time curve",
        "Equation",
        "Outcome",
        "Pediatric",
        "Trough concentration",
        "Vancomycin"
    ],
    "authors": [
        "Pintip Suchartlikitwong",
        "Suvaporn Anugulruengkitt",
        "Noppadol Wacharachaisurapol",
        "Watsamon Jantarabenjakul",
        "Jiratchaya Sophonphan",
        "Tuangtip Theerawit",
        "Tanittha Chatsuwan",
        "Thitima Wattanavijitkul",
        "Thanyawee Puthanakit"
    ],
    "citedby-count": 17,
    "ref-count": 38,
    "ref-list": [
        "Antimicrobial resistance in Gram-positive bacteria",
        "Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States",
        "Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists",
        "Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections",
        "Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary",
        "Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates",
        "Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?",
        "Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia",
        "Vancomycin: we can't get there from here",
        "Are vancomycin trough concentrations adequate for optimal dosing?",
        "Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices",
        "Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children",
        "Impact of initial vancomycin trough concentration on clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children",
        "Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients",
        "Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial",
        "Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter",
        "Vancomycin area under the curve and acute kidney injury: a meta-analysis [published online ahead of print February 1, 2019]",
        "Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation",
        "Improved vancomycin dosing in children using area under the curve exposure",
        "Vancomycin dosing and pharmacokinetics in postoperative pediatric cardiothoracic surgery patients",
        "Vancomycin AUC/MIC and corresponding troughs in a pediatric population",
        "One-compartment open model: intravenous bolus administration",
        "An evaluation of vancomycin area under the curve estimation methods for children treated for acute pulmonary exacerbations of cystic fibrosis due to methicillin-resistant Staphylococcus aureus",
        "Innovative approaches to optimizing the delivery of vancomycin in individual patients",
        "The impact of AUC-based monitoring on pharmacist-directed vancomycin dose adjustments in complicated methicillin-resistant Staphylococcus aureus infection",
        "Measurement and estimation of GFR in children and adolescents",
        "The relationship between vancomycin trough concentrations and AUC/MIC ratios in pediatric patients: a qualitative systematic review",
        "The effect of age and weight on vancomycin serum trough concentrations in pediatric patients",
        "Establishment of an AUC0-24threshold for nephrotoxicity is a step towards individualized vancomycin dosing for methicillin-resistant Staphylococcus aureus bacteremia",
        "Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin",
        "First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand",
        "In vitro activities of linezolid, vancomycin, fosfomycin and fusidic acid against methicillin-resistant Staphylococcus aureus (MRSA)",
        "Diffusion through agar blocks of finite dimensions: a theoretical analysis of three systems of practical significance in microbiology",
        "Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University"
    ]
}